BioTime Reports Second Quarter 2019 Financial Results and Provides Business Update
ALAMEDA, Calif.--(BUSINESS WIRE)--<a href="https://twitter.com/search?q=%24BTX&src=ctag" target="_blank">$BTX</a> <a href="https://twitter.com/hashtag/AMD?src=hash" target="_blank">#AMD</a>--BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing novel cellular therapies for unmet medical needs, reported financial and operating results for the second quarter ended June 30, 2019. BioTime management will host a conference call and webcast today at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time to discuss its second quarter 2019 financial results and to provide a business update. “Over the past several quarters, B